In vitro activities of quinolones against enterococci resistant to penicillin-aminoglycoside synergy.

Antimicrobial Agents and Chemotherapy
D F Sahm, G T Koburov

Abstract

The MICs and MBCs of CI-934, ciprofloxacin, difloxacin (A-56619), A-56620, norfloxacin, enoxacin, amifloxacin, and coumermycin were determined for 43 clinical isolates of Enterococcus faecalis known to be resistant to penicillin-aminoglycoside synergy. Results were compared with those obtained for 37 synergy-susceptible E. faecalis and 22 Enterococcus faecium strains. Although no substantial differences in quinolone activities were observed between synergy-resistant and -susceptible E. faecalis strains, CI-934 and ciprofloxacin were the drugs that demonstrated the greatest bactericidal activity against both types of E. faecalis. The MBCs of the other quinolones were generally within a single twofold dilution of the MICs, but their antienterococcal activity did not approach that of CI-934 or ciprofloxacin. The MBCs for 90% of the isolates of CI-934 for synergy-resistant and -susceptible E. faecalis strains were 1 and less than or equal to 0.5 microgram/ml, respectively. The ciprofloxacin MBC for 90% of the E. faecalis strains tested was 1 microgram/ml. For E. faecium isolates the CI-934 and ciprofloxacin MBCs for 90% of the isolates were 8 and 4 micrograms/ml, respectively. Time-kill assays performed with synergy-susceptible ent...Continue Reading

References

Aug 1, 1979·The Journal of Infectious Diseases·R C MoelleringC B Wennersten
Nov 1, 1979·Antimicrobial Agents and Chemotherapy·T HorodniceanuF Delbos
Dec 1, 1985·Antimicrobial Agents and Chemotherapy·J A MoodyD N Gerding
Jan 1, 1986·Antimicrobial Agents and Chemotherapy·A L BarryR N Jones
Oct 1, 1985·Antimicrobial Agents and Chemotherapy·J S Wolfson, D C Hooper
Feb 1, 1986·Antimicrobial Agents and Chemotherapy·J M StammP B Fernandes
May 1, 1987·Annals of Internal Medicine·M J ZervosD R Schaberg
May 1, 1987·Annals of Internal Medicine·S A Hoffmann, R C Moellering
Jun 1, 1987·Diagnostic Microbiology and Infectious Disease·L R PetersonD N Gerding
Jan 1, 1988·The Journal of Antimicrobial Chemotherapy·M J ZervosC A Kauffman
Aug 1, 1986·The Journal of Antimicrobial Chemotherapy·A KingI Phillips
Mar 1, 1987·Antimicrobial Agents and Chemotherapy·M Fernandez-GuerreroW R Wilson
Dec 1, 1985·Antimicrobial Agents and Chemotherapy·M A CohenJ M Domagala
Apr 1, 1973·Antimicrobial Agents and Chemotherapy·R C MoelleringA J Weinstein
Jan 1, 1983·Antimicrobial Agents and Chemotherapy·J H TenneyG R Chippendale
Mar 1, 1984·Antimicrobial Agents and Chemotherapy·N X Chin, H C Neu
May 1, 1984·Antimicrobial Agents and Chemotherapy·A L BarryH M Sommers
Aug 1, 1980·Journal of Bacteriology·P CourvalinE Collatz
Jun 1, 1984·Antimicrobial Agents and Chemotherapy·H C NeuP Labthavikul
Apr 1, 1983·The Journal of Infectious Diseases·B D Mederski-Samoraj, B E Murray
Sep 1, 1983·The Journal of Clinical Investigation·B E Murray, B Mederski-Samaroj
Mar 1, 1984·Antimicrobial Agents and Chemotherapy·G M EliopoulosR C Moellering
May 1, 1947·The American Journal of Medicine·T H HUNTER

❮ Previous
Next ❯

Citations

Jan 1, 1993·Diagnostic Microbiology and Infectious Disease·P R MurrayC M Hampton
Jan 1, 1995·Diagnostic Microbiology and Infectious Disease·G D HarringtonC A Kauffman
Jan 1, 1991·International Journal of Antimicrobial Agents·H H Gadebusch, D L Shungu
Jan 1, 1991·International Journal of Antimicrobial Agents·E Bergogne-Bérézin
Sep 1, 1996·Diagnostic Microbiology and Infectious Disease·H F BonillaC A Kauffman
Sep 11, 2002·The Lancet Infectious Diseases·David C Hooper
Jun 1, 1995·Journal of Veterinary Pharmacology and Therapeutics·A AnadónM C Fernandez
Feb 1, 1991·Antimicrobial Agents and Chemotherapy·D J Herman, D N Gerding
Nov 1, 1992·Antimicrobial Agents and Chemotherapy·D R SchabergC A Kauffman
Dec 1, 1993·Antimicrobial Agents and Chemotherapy·P FrenchH S Fraimow
Mar 1, 1994·Antimicrobial Agents and Chemotherapy·V KortenB E Murray
Jul 1, 1994·Antimicrobial Agents and Chemotherapy·S BurneyJ M Quale
Oct 12, 2000·Clinical Microbiology Reviews·Y CetinkayaC G Mayhall
Aug 13, 2005·Systematic and Applied Microbiology·Hikmate AbriouelAntonio Gálvez
Jun 4, 2014·International Journal of Antimicrobial Agents·Chun-Hsing LiaoPo-Ren Hsueh
Oct 1, 1993·The Annals of Pharmacotherapy·S A TailorM J Rybak
Apr 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J S Wolfson, D C Hooper
Oct 1, 1995·Clinical Microbiology Reviews·N WoodfordD C Speller
Jul 1, 1990·Clinical Microbiology Reviews·A P JohnsonR C George

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.